Delivery Order SPE2DB22D1106-SPE2DB24FDQL3
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,026.52, is for the delivery of the drug BIDIL 20 MG-37.5 MG TABLET 90S. It is a firm-fixed-price contract with a completion date of November 6, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award is for the delivery of BIDIL 20 MG-37.5 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,937.34 and is a firm fixed-price delivery order with a completion date of June 5, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp (Corporate Office) on January 7, 2026, for the supply of BiDil 20 mg-37.5 mg tablets (90-count packages) with a ceiling value of $6.8K. This is a firm fixed-price delivery order with an ultimate completion date of January 8, 2026, and the place of performance is located in Conshohocken, Pennsylvania. The award was not set aside and was competitively awarded, reflecting AmerisourceBergen's capability to meet...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,773.34, is a delivery order for the supply of AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a pharmaceutical product. The contract has an ultimate completion date of February 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,970.60, is a delivery order for the supply of pharmaceutical products, including AMLOD-VALSA-HCTZ 10-160-12.5MG 30S. The contract has an ultimate completion date of March 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $15,055.71, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999. The IDC, which runs through November 2026, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,362.44, is for the delivery of various pharmaceutical products and medical supplies to support federal healthcare programs, particularly within military and veterans' healthcare systems. The contract has an ultimate completion date of February 4,...
- This federal contract award, valued at $16,200.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,731.54 contract is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $12,570.22, is for the delivery of pharmaceutical products including medications, medical supplies, and devices. The contract is a Firm Fixed Price Delivery Order with a completion date of February 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FDQL3Delivery Order
This contract award, valued at $16,219.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BIDIL 20 MG-37.5 MG TABLET 90S, a pharmaceutical product, and has an ultimate completion date of December 13, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award reviewed does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 12/12/23 |